TCRR
Tcr2 Therapeutics Inc.
President and CEO Garry E Menzel sold $35K of Tcr2 Therapeutics Inc.
Sold$35,034
$1.10Price
31,938Shares
−5%Stake
What TCRR did after the filing
Prices for TCRR after this filing aren't in yet.
Traded Fri, Dec 9. Filed Tue, Dec 13, 3:19 PM ET, during the session. Not investment advice.